Istari Oncology
Durham
About Istari Oncology
Istari Oncology is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The Company was founded in 2016 by Darell Bigner, MD, and Matthias Gromeier, MD to continue research and clinical development of technology discovered at Duke University.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $48.5M
- Last round: Series Unknown (Apr 2021)
- Website: istarioncology.com
- Phone: (919)226-3082
Industries & Categories
Biotechnology, Health Care, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/istari-oncology-3099 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.